[6] Notable stories Stat has broken include one about Robert Califf's research, published after then–President of the United States Barack Obama announced he would be his nominee to lead the Food and Drug Administration.

The site's reporting has also inspired another presidential candidate, Bernie Sanders, to return a contribution that a disgraced former pharmaceutical industry CEO made to his campaign.

[11] Shares of Gilead Sciences, the developer of remdesivir, jumped higher in after-hours trading immediately after the report was published.

[12] In a statement to CNBC, a University of Chicago spokesperson said, “Partial data from an ongoing clinical trial is by definition incomplete and should never be used to draw conclusions about the safety or efficacy of a potential treatment that is under investigation.

"[12] Lloyd Doggett, chair of the House Ways and Means Health Subcommittee, called for an investigation of the leak, noting that "providing information that's designed to impact the stock market is not something that is permitted under federal securities law.